CAS 113627-25-1
:(2R,3S,11bS)-3-isobutil-9,10-dimetoxi-2,3,4,6,7,11b-hexahidro-1H-benzo[a]quinolizin-2-ol
cis-Dihydro Tetrabenazine
CAS:Fórmula:C19H29NO3Cor e Forma:White To Off-White SolidPeso molecular:319.45cis (2,3)-Dihydro Tetrabenazine-d6
CAS:Produto ControladoApplications A labelled metabolite of Tetrabenazine in vivo, which is likely the active pharmacological agent. The cis izomer of Dihydrotetrabenazine is used for the treatment of hyperkinetic movement disorders.
References Kilbourn, M., et al.: Eur. J. Pharmacol., 278, 249 (1995), Perera, R., et al.: J. Med. Chem., 46, 2599 (2003), Mager, D., et al.: J. Pharm. Sci., 94, 2475 (2005), Zheng, G., et al.: Bioorg. Med. Chem., 16, 5018 (2006),Fórmula:C19H23D6NO3Cor e Forma:NeatPeso molecular:325.48rac-(2,3)-Dihydro Tetrabenazine-13C2,D6 [Cis/Trans Mixture]
CAS:Produto ControladoFórmula:C17C2H23D6NO3Cor e Forma:NeatPeso molecular:654.922rac-(2,3)-Dihydro Tetrabenazine [Cis/Trans Mixture]
CAS:Produto ControladoApplications rac-(2,3)-Dihydro Tetrabenazine [Cis/Trans Mixture] is a mixture of cis-2,3-Dihydro Tetrabenazine (D449650) and trans-2,3-Dihydro Tetrabenazine (D449655); used in the treatment of hyperkinetic movement disorders.
References Kilbourn, M., et al.: Eur. J. Pharmacol., 278, 249 (1995); Perera, R., et al.: J. Med. Chem., 46, 2599 (2003); Mager, D., et al.: J. Pharm. Sci., 94, 2475 (2005); Zheng, G., et al.: Bioorg. Med. Chem., 16, 5018 (2006)Fórmula:C19H29NO3Cor e Forma:NeatPeso molecular:638.877cis (2,3)-Dihydro Tetrabenazine
CAS:Produto ControladoApplications A metabolite of Tetrabenazine in vivo, which is likely the active pharmacological agent. The cis isomer of Dihydrotetrabenazine is used for the treatment of hyperkinetic movement disorders.
References Kilbourn, M., et al.: Eur. J. Pharmacol., 278, 249 (1995), Perera, R., et al.: J. Med. Chem., 46, 2599 (2003), Mager, D., et al.: J. Pharm. Sci., 94, 2475 (2005), Zheng, G., et al.: Bioorg. Med. Chem., 16, 5018 (2006),Fórmula:C19H29NO3Cor e Forma:NeatPeso molecular:319.44


